India, April 22 -- Research driven Pharmaceutical giant Boehringer Ingelheim registered net sales of 17.5 billion Euros in 2018 and with net sales of 12.6 billion euros of the human pharma division its share share in total net sales was 72 per cent. The company is investing 230 million euros to expand and improve its biopharmaceutical development capacities.

"Compare to the earlier year, on one hand the currency effects have had significant negative impact on the net sales and on the other hand decline in net sales from discontinued operations plays a significant role," Michael Schmelmer, Member of the Board of Managing Directors responsible for Finance, told a press conference at the company headquarter here.

Still, the income before t...